Skip to main content
. 2015 Mar 30;6(17):15180–15193. doi: 10.18632/oncotarget.3737

Figure 2. miR-572 promotes cell proliferation and cell-cycle progression in ovarian cancer cells.

Figure 2

(A) Effects of ectopic overexpression of miR-572 on the proliferation of the indicated ovarian cancer cell lines, as analyzed by the MTT assay. (B) Representative micrographs (left) and quantification (right) of colonies formed by the indicated ovarian cancer cell lines at 10 days after inoculation in the colony formation assay. (C) Representative micrographs (left) and quantification (right) of BrdUrd incorporating-cells for the indicated ovarian cancer cells. (D) Flow cytometric analysis of the effect of miR-572 overexpression on cell cycle progression for the indicated ovarian cancer cells. Experiments were repeated at least three times with similar results; values are mean ± SD; * P < 0.05.